Rojas-Domínguez R, Cruz-Y-López-Othón R, Vázquez-Hernández PA, Cárdenas-Perea ME

Language: Spanish
References: 16
Page: 232-236
PDF size: 655.09 Kb.

ABSTRACT

Introduction: we present the case of a patient diagnosed with visceral leishmaniasis treated at a hospital in Puebla, Mexico, to highlight the diagnostic and therapeutic challenges. Case description: a one-year-eleven-month-old girl from a municipality in Puebla was admitted with persistent fever, hepatosplenomegaly, and pancytopenia. The diagnosis was established by bone marrow aspiration and culture, complemented by histopathological and biochemical studies, which confirmed the presence of Leishmania sp. and showed marked hypergammaglobulinemia. Treatment with meglumine antimoniate (20 mg/kg/day for 20 days) was prescribed, resulting in complete clinical and hematological resolution. Conclusions: this case, documented in an area with recorded transmission of the parasite, underscores the need to maintain a high index of clinical suspicion in pediatric patients with prolonged fever and visceromegaly.

REFERENCES

1. Beltrán-Silva SL, Martínez-Domínguez R, Enríquez-Gallegos M, Santos-Preciado JI. Leishmaniasis visceral: veinte años de experiencia clínica en población pediátrica en un hospital de referencia en Chiapas. Bol Med Hosp Infant Mex. 2011; 68(2): 91-96.

2. López-Flores J, Vadillo-Ortega F, Muñoz-Hernández O, Vargas-Valerio A. Leishmaniasis visceral en un lactante menor: reporte de caso. Rev Enf Infecc Pediatr. 2008; 21(82): 88-93.

3. Hernández-Flores JJ, Morales-Aguirre JJ, Zamora-Chávez A. Leishmaniasis visceral tratada con anfotericina B. Bol Med Hosp Infant Mex. 2007; 64(1): 43-48.

4. Romano Mazzotti L, Carreño Manjarrez R, Maldonado Velázquez R, Gamboa Marrufo JD. Leishmaniasis visceral: reporte de un caso. Bol Med Hosp Infant Mex. 2004; 61(4): 341-347.

5. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017; 6: 750. doi: 10.12688/f1000research.11120.1.

6. Cruz-Hernández V, León-Tapia S, Cruz-Reyes MA, Ramírez-Moreno E, Pérez-Hernández A et al. Leishmaniasis visceral: reporte de cuatro casos y revisión de la bibliografía. Med Int Mex. 2013; 29(2): 204-209.

7. Scarpini S, Dondi A, Totaro C, Biagi C, Melchionda F, Zama D et al. Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms. 2022; 10(10): 1887. doi: 10.3390/microorganisms10101887.

8. Pastor-Santiago JA, Chávez-López S, Guzmán-Bracho C, Flisser A, Olivo-Díaz A. American visceral leishmaniasis in Chiapas, Mexico. Am J Trop Med Hyg. 2012; 86(1): 108-114. doi: 10.4269/ajtmh.2012.10-0561.

9. Cruz-López O, Tamariz-Cruz O, Gándara-Ramírez JL, Rojas-Domínguez R, Cárdenas-Perea ME. Un caso de leishmaniasis visceral. Rev Invest Clin. 1997; 49(3): 231-235.

10. Rocha R, Conceicao C, Goncalves L, Maia C; LeishPT Group. Epidemiological and clinical trends of visceral leishmaniasis in Portugal: retrospective analysis of cases diagnosed in public hospitals between 2010 and 2020. Infect Dis Poverty. 2024; 13(1): 41. doi: 10.1186/s40249-024-01204-5.

11. Duarte AGS, Werneck GL, de Farias Lelis S, Mendonca TS, Vasconcelos DD, Gontijo TS et al. An updated systematic review with meta-analysis and meta-regression of the factors associated with human visceral leishmaniasis in the Americas. Infect Dis Poverty. 2025; 14(1): 4. doi: 10.1186/s40249-025-01274-z.

12. Zou L, Chen G, Zhou Y, Ye W, Wen Y, Chen L et al. Continuous hypergammaglobulinemia and proteinuria after the recovery of the visceral Leishmaniasis: a case report. BMC Infect Dis. 2021; 21(1): 124. doi: 10.1186/s12879-021-05819-z.

13. Van Dijk NJ, Amer S, Mwiti D, Schallig HDFH, Augustijn EW. An epidemiological and spatiotemporal analysis of visceral leishmaniasis in West Pokot, Kenya, between 2018 and 2022. BMC Infect Dis. 2024; 24(1): 1169. doi: 10.1186/s12879-024-10053-4.

14. Organización Panamericana de la Salud. Leishmaniasis: informe epidemiológico de las Américas, núm. 13, diciembre 2024 [Internet]. Washington, D.C.: OPS; 2024. Disponible en: https://www.paho.org/es/documentos/leishmaniasis-informe-epidemiologico-americas-num-13-diciembre-2024

15. Soares AGR, Landim JS, Franca NG, de Alencar Filho EB, do Carmo RF. Differential diagnosis of visceral leishmaniasis in children: a five-year retrospective study at a pediatric referral hospital. BMC Pediatr. 2024; 24(1): 726. doi: 10.1186/s12887-024-05160-9.

16. Romero GAS, Boelaert M. Control of visceral leishmaniasis in Latin America—A systematic review. PLoS Negl Trop Dis. 2010; 4(1): e584. https://doi.org/10.1371/journal.pntd.0000584